Figure 3 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma by Jessica D. Daley (22128489)

Data Sheet 1_Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.pdf by Jingjing Fang (124938)

Table 1_Fertilization decreases the effect of ammonium nitrogen on microorganisms in Chinese Carex tibetikobresia meadows during rest-grazing.docx by Xuanbo Zhou (19374205)

Image 2_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 5_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 1_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

General and sociodemographic characteristics of the EBF and EBF+ groups. by Larissa Brazolotto Ferreira (17671168)

Subjects:

Flowchart of the exclusive breastfeeding mothers (EBF) and the exclusive breastfeeding mother-donors (EBF+) who participated in the study. by Larissa Brazolotto Ferreira (17671168)

Subjects:

Timeline of monitoring of exclusive breastfeeding mothers (EBF) and exclusive breastfeeding – donors (EBF+). by Larissa Brazolotto Ferreira (17671168)

Subjects:

I Optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

Subjects:

ANOVA for I optimal design of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

Subjects:

The kinetic release data of the optimized formula compared to drug suspension. by Randa Mohammed Zaki (21637175)

Subjects:

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

Subjects:

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. by Randa Mohammed Zaki (21637175)

Subjects:

Comparison of densitometric, biochemical, and hormonal variables, and bone turnover markers of EBF + 6 months versus EBF + one year postpartum. by Larissa Brazolotto Ferreira (17671168)

Subjects:

Comparisons between densitometric, biochemical, and hormonal variables and bone remodeling markers of exclusive breastfeeding mothers (EBF) 15 days postpartum and the same EBF moth... by Larissa Brazolotto Ferreira (17671168)

Subjects:

Anthropometric, nutritional, and variable assessments of lean mass and fat mass obtained by DXA of exclusive breastfeeding mothers (EBF), at pre-pregnancy, baseline (15 days), and... by Larissa Brazolotto Ferreira (17671168)

Subjects:

Open data. by Larissa Brazolotto Ferreira (17671168)

Subjects: